Altshuler Shaham’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18
| Closed | -$18.9K | – | 420 |
|
|
2024
Q3 | $18.9K | Buy |
+18
| New | +$20K | ﹤0.01% | 196 |
|
|
2023
Q3 | – | Sell |
-412
| Closed | -$296K | – | 339 |
|
|
2023
Q2 | $296K | Sell |
412
-132
| -24% | -$102K | 0.01% | 95 |
|
|
2023
Q1 | $447K | Sell |
544
-106
| -16% | -$79.9K | 0.01% | 78 |
|
|
2022
Q4 | $469K | Sell |
650
-276
| -30% | -$204K | 0.02% | 67 |
|
|
2022
Q3 | $641K | Sell |
926
-285
| -24% | -$179K | 0.02% | 87 |
|
|
2022
Q2 | $716K | Buy |
1,211
+1,062
| +713% | +$690K | 0.01% | 90 |
|
|
2022
Q1 | $104K | Sell |
149
-47
| -24% | -$29.7K | ﹤0.01% | 262 |
|
|
2021
Q4 | $124K | Sell |
196
-149,984
| -100% | -$92.2M | ﹤0.01% | 314 |
|
|
2021
Q3 | $146K | Buy |
150,180
+149,259
| +16,206% | +$92.7M | ﹤0.01% | 283 |
|
|
2021
Q2 | $515K | Buy |
921
+127
| +16% | +$64.3K | ﹤0.01% | 198 |
|
|
2021
Q1 | $376K | Sell |
794
-39
| -5% | -$19K | ﹤0.01% | 151 |
|
|
2020
Q4 | $402K | Sell |
833
-1,210
| -59% | -$653K | 0.01% | 127 |
|
|
2020
Q3 | $1.14M | Buy |
2,043
+1,273
| +165% | +$772K | 0.03% | 72 |
|
|
2020
Q2 | $480K | Buy |
770
+692
| +887% | +$393K | 0.01% | 104 |
|
|
2020
Q1 | $38K | Sell |
78
-3,327
| -98% | -$1.37M | ﹤0.01% | 198 |
|
|
2019
Q4 | $1.28M | Buy |
+3,405
| New | +$1.15M | 0.04% | 70 |
|
|
2019
Q3 | – | Sell |
-4,424
| Closed | -$1.39M | – | 538 |
|
|
2019
Q2 | $1.39M | Buy |
4,424
+4,379
| +9,731% | +$1.46M | 0.06% | 62 |
|
|
2019
Q1 | $18K | Buy |
45
+24
| +114% | +$9.88K | ﹤0.01% | 195 |
|
|
2018
Q4 | $8K | Buy |
+21
| New | +$7.69K | ﹤0.01% | 208 |
|
|
2018
Q1 | – | Sell |
-5,731
| Closed | -$2.15M | – | 221 |
|
|
2017
Q4 | $2.15M | Buy |
+5,731
| New | +$2.32M | 0.31% | 28 |
|
Other funds holding REGN
